Intervention

Biopsy of breast

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions4

Lead sponsors shown1

Clinical trials

1 shown

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast CancersNCT05919108 · 2024-06-11

RECRUITING

Common conditions

Anatomic Stage I Breast Cancer1 Anatomic Stage II Breast Cancer1 Anatomic Stage III Breast Cancer1 Invasive Breast Lobular Carcinoma1

Leading sponsors

Vanderbilt-Ingram Cancer Center1

Trial status mix

RECRUITING1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.